E. Santos-Lima

Role of co-stimulation in CD8+ T cell activation.

N. Pardigon, P. Kourilsky, N. Bercovici, 1998, International immunology.

Antibody Persistence and Booster Vaccination of a Fully Liquid Hexavalent Vaccine Coadministered With Measles/Mumps/Rubella and Varicella Vaccines at 15–18 Months of Age in Healthy South African Infants

S. Madhi, C. Cutland, M. Groome, 2013, The Pediatric infectious disease journal.

Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim) following primary series administration at 2, 4, 6 months of age in Latin America.

S. B'chir, A. Lane, E. Santos-Lima, 2013, Vaccine.

A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children.

B. Zambrano, M. Macías, E. Santos-Lima, 2012, Vaccine.

Immunogenicity and Safety of an Investigational Hexavalent Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus-hepatitis B-Haemophilus influenzae B Conjugate Combined Vaccine in Healthy 2-, 4-, and 6-month-old Argentinean Infants

B. Zambrano, Miguel W. Tregnaghi, E. Santos-Lima, 2011, The Pediatric infectious disease journal.

Significant association between the skewed natural antibody repertoire of Xid mice and resistance to Trypanosoma cruzi infection

A. Coutinho, B. Reina-San-Martin, P. Minoprio, 2001, European journal of immunology.

Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants.

S. Benjaponpitak, U. Thisyakorn, K. Chokephaibulkit, 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10-45 years.

B. Zambrano, Miguel W. Tregnaghi, E. Santos-Lima, 2010, Vaccine.

Immunogenicity and Safety of an Investigational Fully Liquid Hexavalent Combination Vaccine Versus Licensed Combination Vaccines at 6, 10, and 14 Weeks of Age in Healthy South African Infants

S. Madhi, I. Mitha, C. Cutland, 2011, The Pediatric infectious disease journal.

Safety and Immunogenicity of an Investigational Fully Liquid Hexavalent DTaP-IPV-Hep B-PRP-T Vaccine at Two, Four and Six Months of Age Compared With Licensed Vaccines in Latin America

C. Lanata, A. Gil, B. Zambrano, 2012, The Pediatric infectious disease journal.